How to calculate a Prismaflex (Continuous Renal Replacement Therapy) SCRRT (Sustained Low-Efficiency Dialysis) on hemodialysis modality?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Calculating Prismaflex CRRT in Hemodialysis Modality (CVVHD)

For Prismaflex CVVHD (continuous venovenous hemodialysis), the dialysate flow rate directly determines small solute clearance, following the formula: Clearance (K) = Dialysate flow rate (Qd) ÷ 60, where Qd is in mL/hour and clearance is in mL/min. 1

Blood Flow Rate Settings

  • Set blood flow (Qb) at 100-200 mL/min for standard CVVHD on the Prismaflex system 2
  • Blood flow rates of 120 mL/min are commonly used in clinical practice with the Prismaflex device 3
  • For pediatric or low-body-weight patients, blood flow can be reduced to 30-50 mL/min while maintaining efficacy 2

Dialysate Flow Rate Prescription

  • Target dialysate flow rate of 1,000-2,000 mL/hour (16.7-33.3 mL/min clearance) for standard CVVHD 2, 1
  • The Prismaflex with standard circuits limits dialysate flow to approximately 1,000 mL/hour maximum 2
  • To achieve the recommended effluent dose of 20-25 mL/kg/hour, calculate: Qd (mL/hour) = patient weight (kg) × 20-25 2

Calculating Delivered Dose

  • For CVVHD, the delivered dose equals the dialysate flow rate since there is minimal ultrafiltration beyond net fluid removal 2
  • Example: For a 70 kg patient requiring 25 mL/kg/hour dose:
    • Required Qd = 70 kg × 25 mL/kg/hour = 1,750 mL/hour
    • This provides clearance of 1,750 ÷ 60 = 29.2 mL/min 1

Small Solute Clearance Prediction

  • Clearance of urea nitrogen, creatinine, and uric acid during CVVHD closely approximates the dialysate flow rate divided by 60 1
  • The formula Kd = Qd/60 has been validated with very significant correlation (P < 0.001) between calculated and observed clearances 1
  • Phosphate clearance may be slightly less predictable than other small solutes during CVVHD 1

Ultrafiltration Rate Calculation

  • Net ultrafiltration rate = Patient fluid removal goal (mL/hour) separate from dialysate flow 2
  • Set the Prismaflex to achieve desired hourly fluid removal based on patient volume status
  • Total effluent = Dialysate flow + Net ultrafiltration rate 2

Key Operational Parameters

  • Use PrismOcal or equivalent bicarbonate-based dialysate at the prescribed flow rate 2, 3
  • Membrane choice: AN69ST (Prisma Flex ST100) or M150 filters are standard options 3, 4
  • Anticoagulation: Regional citrate is preferred if no contraindications exist 2

Critical Pitfall to Avoid

  • Do not confuse CVVHD with CVVH (hemofiltration): In CVVH, clearance depends on ultrafiltration rate and blood flow following K(UF) = (Q(UF)/60) × Q(B)/(Q(B) + Q(UF)/60), whereas in CVVHD, clearance is determined solely by dialysate flow rate 1
  • CVVHD is more efficient than CVVH for removing small molecular weight solutes but less efficient for larger molecules like beta-2-microglobulin 1

Monitoring Requirements

  • Measure delivered dose frequently as prescribed dose often exceeds actual delivered dose 2
  • Monitor electrolytes every 4-6 hours, particularly calcium, phosphate, potassium, and magnesium 2, 5
  • Warm dialysate to maintain hemodynamic stability during treatment 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.